Bull Market Buys: 2 Growth Stocks to Own for the Long Run [Yahoo! Finance]
Vertex Pharmaceuticals Incorporated (VRTX)
Last vertex pharmaceuticals incorporated earnings: 4/29 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.vrtx.com
Company Research
Source: Yahoo! Finance
Since then, the major indexes -- the S&P 500 , the Nasdaq Composite , and the Dow Jones Industrial Average -- have delivered total returns of 57%, 72%, and 40%, respectively. Historically, bull markets have lasted anywhere from months to many years, with the average bull market lasting around three years. While no one can predict how long this bull market will last, if you're investing in high-quality businesses with durable competitive advantages, you can stay invested in those stocks through multiple market cycles. If you're hunting for top stocks to buy, here are two fantastic contenders to consider now. 1. Vertex Pharmaceuticals Vertex Pharmaceuticals (NASDAQ: VRTX) has been on a winning streak lately, both as a business and as a stock. From a share price perspective, investors have enjoyed a run up of about 36% over the trailing 12 months. The healthcare company specializes in developing drugs that target various rare diseases. It's cut its teeth in the cystic fibrosis
Show less
Read more
Impact Snapshot
Event Time:
VRTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VRTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VRTX alerts
High impacting Vertex Pharmaceuticals Incorporated news events
Weekly update
A roundup of the hottest topics
VRTX
News
- Vertex (VRTX) NDA for Vanza Triple Therapy Accepted by FDA [Yahoo! Finance]Yahoo! Finance
- Vertex Announces FDA Acceptance of New Drug Application for Vanzacaftor/Tezacaftor/Deutivacaftor, a Next-In-Class Triple Combination Treatment for Cystic Fibrosis [Yahoo! Finance]Yahoo! Finance
- Vertex Announces FDA Acceptance of New Drug Application for Vanzacaftor/Tezacaftor/Deutivacaftor, a Next-In-Class Triple Combination Treatment for Cystic FibrosisBusiness Wire
- Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.MarketBeat
- Vertex to Announce Second Quarter 2024 Financial Results on August 1Business Wire
VRTX
Earnings
- 5/6/24 - Beat
VRTX
Sec Filings
- 6/28/24 - Form 4
- 6/27/24 - Form 8-K
- 6/26/24 - Form 144
- VRTX's page on the SEC website